In several EU countries, the corona vaccination with the AstraZeneca vaccine has been discontinued for the time being.
The EMA gives the all-clear, but points out possible side effects.
Amsterdam - anaphylaxis and hypersensitivity - these two reactions are to be added to the list of possible side effects of AstraZeneca's corona vaccine.
According to the European Medicines Agency (EMA), the British-Swedish vaccine manufacturer's vaccine can in rare cases trigger these severe allergic reactions.
AstraZeneca corona vaccine: EMA points out anaphylaxis and hypersensitivity
There are reports of 41 possible anaphylaxis cases among five million vaccinated people in the UK, the EMA said on Friday.
After a careful analysis of the data, the committee responsible for vaccine risk assessment considers a connection between the allergic reaction and the vaccination to be at least in some cases probable, according to the authority based in Amsterdam.
At the same time, however, the EMA pointed out that severe allergic reactions are a known, rare side effect even with vaccinations against other diseases.
The package insert for the AstraZeneca vaccine against the coronavirus * already recommends that patients should remain under observation for at least 15 minutes after a vaccination in order to be able to react to possible allergic reactions.
Corona vaccine from AstraZeneca: vaccination bans in several EU countries
Some states in the EU had already announced that they would stop corona vaccinations * with the AstraZeneca vaccine for the time being.
Denmark announced on Thursday that it would suspend vaccinations with the British-Swedish company's preparation for 14 days.
The reason given by the Danish health administration was reports of severe blood clots after people had been vaccinated with the drug.
+
Several EU countries have discontinued the corona vaccination with the AstraZeneca vaccine for the time being.
(Symbol image)
© Ronny Hartmann / dpa
There was also a death in Denmark *.
At the same time, however, the Danes made it clear that it was not yet possible to determine whether there was a connection between the vaccine and the blood clots.
Other countries such as Norway, Iceland and Bulgaria also suspended vaccinations with the AstraZeneca agent.
In Austria, due to the death of a nurse and three other illnesses *, the use of a certain batch was suspended as a precaution.
Sweden and Poland, however, said they would continue to use the AstraZeneca vaccine.
Corona vaccine from AstraZeneca: Spahn regrets vaccination stop - "benefit far greater than risk"
"I regret that on this basis - as of Friday morning - some countries in the European Union have suspended vaccination with AstraZeneca," said Federal Health Minister Jens Spahn (CDU) at a press conference on the current Corona situation in Germany on Friday in Berlin.
He referred to an assessment by the EMA, according to which there was no noticeable accumulation of thromboses in the temporal connection with the AstraZeneca vaccination.
By March 10, 30 cases of "thromboembolic events" had been recorded in almost five million people who had been vaccinated with the vaccine.
The World Health Organization (WHO) agreed with this assessment, as did the Paul Ehrlich Institute (PEI) responsible for Germany.
"With what we know so far, the benefit is far greater than the risk," assured Spahn.
Lothar Wieler, President of the Robert Koch Institute (RKI) *, explained that there had been no evidence so far "that these events would be statistically conspicuous".
Austria's Chancellor Sebastian Kurz (ÖVP) * also campaigned for confidence in the AstraZeneca vaccine on Friday.
"Since there are many people who are concerned, I will also be vaccinated with AstraZeneca to show that I have confidence in the vaccine," announced Kurz.
AstraZeneca corona vaccine: manufacturer rejects worries about side effects
The British-Swedish pharmaceutical company itself has also rejected concerns about serious side effects of the corona vaccination *.
"An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis," a spokesman assured on Friday.
This applies to all ages, genders, countries or batches of the AstraZeneca vaccine.
"In fact, these events occur less frequently among vaccinated people than in the general population," the spokesman continued.
(ph / dpa / afp) * Merkur.de is an offer from IPPEN.MEDIA
List of rubric lists: © Ronny Hartmann
